Evidence map›Paper›PMID 26989677›Full record

ArticleBioMed research international2016

Novel Biomarkers and Treatments of Cardiac Diseases.

Hua Zhu, Renzhi Han, Dayue Darrel Duan

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hua ZhuDepartment of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Wexner Medical Center, Columbus, OH 43210, USA.
Renzhi HanDepartment of Surgery, Davis Heart and Lung Research Institute, The Ohio State University, Wexner Medical Center, Columbus, OH 43210, USA.
Dayue Darrel DuanLaboratory of Cardiovascular Phenomics, Center for Cardiovascular Research, Department of Pharmacology, and Center for Molecular Medicine, University of Nevada School of Medicine, Reno, NV 89557-0318, USA.

Funding

Molecular and cellular functions of Ano5 in heartR01HL116546 · NHLBI · OHIO STATE UNIVERSITY · PI HAN, RENZHI · 2013 to 2022
$4.4M
Oxidized Low-density Lipoprotein Impairs Bone Marrow Stem Cell SurvivalR01HL124122 · NHLBI · OHIO STATE UNIVERSITY · PI LIU, ZHENGUO, ZHU, HUA · 2015 to 2018
$2.1M
Mechanisms of Muscle Inflammation in Muscular DystrophyR01AR064241 · NIAMS · OHIO STATE UNIVERSITY · PI HAN, RENZHI · 2013 to 2017
$1.5M
The CLC-3 chloride channels in the heartR01HL113598 · NHLBI · UNIVERSITY OF NEVADA RENO · PI DUAN, DAYUE DARREL · 2013 to 2016
$1.4M
NHLBI NIH HHS R01 HL113598NHLBI NIH HHS R01 HL116546NHLBI NIH HHS R01 HL124122NIAMS NIH HHS R01 AR064241
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersHeart DiseasesHumansBiomarkers

Identifiers

PMID26989677
PMCPMC4773528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.